Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Nalmefene is an antagonist of μ- and κ-opioid receptors (Kis = 0.91 and 1.03 nM, respectively, in CHO membranes expressing the human receptors).1 It is selective for μ- and κ-opioid receptors over δ-opioid receptors (Ki = 13.26 nM in CHO membranes expressing the human receptors). Nalmefene decreases self-administration of alcohol in non-alcohol- and alcohol-dependent rats.2 It reduces food and water intake and body weight in obese and lean rats when administered at a dose of 25 mg/kg per day.3 Nalmefene (32 mg/kg) inhibits morphine-induced scratching behavior and increases in the latency to tail withdrawal in a warm water tail withdrawal assay in rhesus monkeys.4 Formulations containing nalmefene have been used in the treatment of opioid overdose.
WARNING This product is not for human or veterinary use.
1. Synthesis and biological evaluation of α-
2. Pharmacological evidence for a motivational role of κ-
3. Nalmefene decreases meal size, food and water intake and weight gain in Zucker rats. Pharmacol. Biochem. Behav. 19(2), 235-240 (1983).
4. An experimental itch model in monkeys: Characterization of intrathecal morphine-